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because of their
direct influence in the
immunological response
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Abstract
Polyunsaturated fatty acids
(PUFAs) such as docosahexaneoic
acid (DHA) and eicosapentaneoic
acid (EPA), play a critical role in
a variety of neuronal functions,
including facilitating neuronal
growth and differentiation,
increasing the density of the
neuritic network, modulating cell
membrane fluidity, regulating
intracellular signaling and
gene expression, and exhibiting
antioxidant characteristics.
Dietary DHA is selectively
enriched and actively retained
in the central nervous system,
mainly in synaptic membranes,
dendrites, and photoreceptors.
In this review, we highlight
the myriad roles of PUFAs in
brain function and human
health. Diets rich in DHA
are inversely proportional to
cognitive decline and incidence
of neurodegenerative disorders.
Conversely, diets deficient
in DHA impair the proper
development of brain and the
visual system in children and
increase risk of brain disorders
in the elderly. Finally, DHA and
EPA have been shown to reduce
inflammation and may prove
to be beneficial in reducing the
severity of the SARS-COVID
infection.
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Introduction:
Polyunsaturated Fatty Acids
Polyunsaturated fatty acids
(PUFAs) are required for optimal
human health and wellbeing.
PUFAs are classified by the
position of the first double bond
in a fatty acid counting from
the methyl end. There are two
major classes of PUFAs: omega-6
fatty acids (first double bond is
at the sixth carbon from methyl
end) and omega-3 fatty acids
(first double bond is at the third
carbon from methyl end). PUFAs
are derived from essential fatty
acids (EFA) such as linoleic acid
(LA) and alpha-linolenic acid
(ALA), fatty acids that cannot
be synthesized in the body and
need to be ingested through diet.
The parent omega-6 fatty acid,
LA is desaturated in the body
to form arachidonic acid while
parent omega-3 fatty acid ALA
is desaturated by a microsomal
enzyme system to form DHA and
EPA. However, there is a limited
metabolic capability in humans
for this conversion underscoring
the need for their inclusion in
diet.
PUFAs and Brain Health
EFAs and PUFAs and their
metabolic products play a critical
role in the maintenance of
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structural and functional integrity of the central
nervous system and retina.1 Extensive research
has shown their crucial role in maintaining
neuronal homeostasis. PUFA’s exert their
effects through modulating the fluidity of
the neuronal membrane, regulating signal
transduction, promoting neurite outgrowth,
and impacting the function of key ion channels
and receptors.2 DHA has also been shown to
influence cell membrane fluidity by promoting
signaling interactions between macromolecules
to form lipid rafts: cholesterol and sphingolipidenriched microdomains in the plasma
membrane, known to serve as local sites for
housing signaling proteins, and orchestrating
key signaling processes.3 The most extensively
studied PUFA is the omega-3 fatty acid called
DHA.2 This is the most abundant fatty acid
in the brain and is a structural component of
the neuronal membrane. DHA plays a critical
role in neuronal growth and differentiation,
neuronal signaling, synthesis of bioactive
mediators, synaptic plasticity, and remodeling
of the neuritic network.4 Diets high in DHA are
inversely proportional to cognitive decline and
the onset of neurodegenerative disorders, such
as Alzheimer’s disease and Parkinson’s disease.
As mentioned above, DHA (22:6 n-3)
is a product of ALA, an essential fatty acid
that must be obtained from the diet. There is
a significant body of evidence showing that
a high (n-3):(n-6) dietary intake ratio, such
as in the Mediterranean diet, has widespread
positive health effects.5 Mediterranean diets
have lower intakes of added sugar, saturated
fat, trans-fat, lower glycemic index, and a lower
ratio of (n-6):(n-3) fatty acids. This type of diet
appears to reduce risk for Alzheimer’s disease
and other forms of dementia. Additionally,
a Mediterranean diet includes most of the
nutritional components important for lowering
risk for cardiovascular disease, hypertension,
and type II diabetes.6
Western diets are low in omega-3 fatty
acids, including ALA found mainly in plant
oils, and DHA, which is found in fish.
Epidemiological studies have linked low

maternal DHA to increased risk of poor neural
development in infants.7 Dietary deficiency
of n-3 fatty acids during fetal development in
utero and postnatal state has shown negative
effects on cognitive abilities and a loss of
discriminative learning ability.8 Intervention
studies have shown that improving maternal
DHA intake decreases the risk of poor visual
and neural development in children. Sufficient
evidence has concluded the occurrence of
efficient transfer of DHA from mother to
fetus before birth and during lactation after
birth, with short and long-term implications
for neural function. Most of the brain growth
is completed by five to six years of age. It
is recommended for pregnant and nursing
women to take at least 2.6 g of omega-3 fatty
acids and 100-300 mg of DHA daily to meet
the needs of the fetus and suckling infant.1
Follow-up studies have shown that infants of
mothers who took supplements of EFAs and
DHA have higher mental processing scores,
eye-hand coordination, psychomotor scores,
and stereo acuity at four years of age. Intake
of EFAs and DHA during preschool years may
have a beneficial role in prevention of attention
deficit hyperactivity disorder and enhancing
capability and academic performance.1
Although a good natural source of PUFAs
is seafood, especially oily fish, one can obtain
them via consuming fish oil capsules. Very
long chain omega-3 fatty acids are readily
incorporated from capsules into transport
(blood lipids), functional (cell and tissue), and
storage (adipose) pools.9 At sufficient levels
of incorporation, EPA and DHA influence
the physical nature of cell membranes and
membrane protein-mediated responses,
increase the generation of bioactive lipids, and
promote cell signaling and gene expression
in many different cell types.9 Through these
mechanisms, they impact overall cellular
homeostasis and modulate the cellular
response to external signals. In most cases the
effects seen are associated with improvements
in disease biomarker profiles and healthrelated outcomes.9 Given that the capacity
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Figure 1. Mechanism of action
of docosahexaenoic acid.
Docosahexaenoic acid (DHA) binds
to the G protein coupled receptor
GPR-40 which leads to the activation
of phospholipiase C (PLC),
conversion of phosphatidylinositol
4,5-bisphosphate (PIP2) to form
diacylglycerol (DAG) and inositol
tris phosphate (IP3), which activates
the IP3 receptor leading to the
release of calcium from ER stores.
The increase of intracellular Ca2+
activates protein kinase C (PKC)
which leads to synaptogenesis
Adapted from Ma et al., 2010, DHA promotes the neuronal
differentiation of rat neural stem cells transfected with
GPR40 gene, Brain Research, 2010, 1330, 1 – 8.

of the human brain to synthesize DHA locally
is appreciably low, the uptake of DHA from
circulating lipid pools is essential to maintaining
its homeostatic levels. Although, several plasma
pools have been proposed to supply the brain
with DHA, recent evidence suggests nonesterified-DHA and lysophosphatidycholineDHA are the primary sources.10 The uptake of
DHA and its enrichment in the brain appears to
be regulated by several complementary pathways
associated with its metabolism. Following entry
into the brain, DHA is esterified into and
recycled amongst membrane phospholipids and
converted to bioactive mediators which regulate
signaling pathway important to synaptogenesis,
cell survival, and neuroinflammation, and may
be relevant to treating neurological diseases.10
Role of DHA in Neurite Formation in
Brain
DHA is a critical component in the
development of neurons and neurites in young
mammals, since its peak concentration has
been observed to be in the late gestational
period.11 However, it has been shown that
DHA plays a critical role in the adult brain
as well. DHA accounts for roughly 15% of
the fatty acid content in the mature human
brain, and it is believed that decreased levels
can lead to cognitive decline and the onset
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of neurodegenerative diseases, such as
Alzheimer’s disease and Parkinson’s disease.4
Various studies have been done to unravel the
precise mechanisms underlying the protective
and proliferative properties of DHA in the
brain. One study found the DHA to be an
endogenous ligand for the G protein coupled
receptor called GPR40, which is expressed
in the hippocampus of adult monkeys, and
was shown to be associated with neurogenesis
after ischemia.12 It is important to note that
the hippocampus, an area of the brain critical
for memory, is especially sensitive to changes
in membrane fluidity, hence DHA levels are
likely to have a more substantial impact in this
region. Interaction of DHA with the GPR40
was found to be responsible for promoting
neurogenesis and neuritogenesis. This effect was
mediated through increase in intracellular Ca2+
which was released via activation of inositol tris
phosphate receptor (IP3-R) (Figure 1). This
finding implies that DHA, at least partially, acts
through the IP3 receptor-mediated signaling.12
Role of DHA in Cognitive Decline
A significant body of literature supports
the role of DHA in overall brain function,
including neuronal growth and differentiation
as well as optimizing neuronal signaling. Most
data from human studies show its contribution
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to optimal visual acuity development, an
assertion supported by the presence of high
amounts of DHA in rod outer segment
membranes.13 While DHA levels affect early
brain development in infants, potential effects
are also increasingly observed during adult
life. Epidemiological studies support a link
between low dietary intake of DHA and a
higher risk of cognitive decline and onset of
neurodegenerative and psychiatric disorders.14
The primary insult from loss of DHA from
membrane glycerophospholipids, is on the
flexibility and fluidity of membrane lipids
which in turn affects the optimal function
of critical integral membrane proteins
(receptors, voltage-gated ion channels and
enzymes).15 This leads to effects on second
messenger systems, neurotransmitter release,
and subsequent downstream cascade likely to
have deleterious changes in brain and visual
function. Many studies have also reported that
dietary omega-3 deficiency results in changes
in learning, coping with stress, behavioral
changes, and responses in visual function.13
Circulating plasma DHA is significantly
related to cognitive abilities during aging,
and is inversely associated with cognitive
decline. A diet characterized by higher intakes
of foods containing high levels of n-3 fatty
acids, and/or lower intake of n-6 fatty acids is
strongly associated with a lower incidence of
Alzheimer’s disease and other brain disorders.
Supplementation of DHA improves some
behaviors associated with attention deficit
hyperactivity, bipolar disorder, schizophrenia,
and impulsive behavior, as well as cognition.8
DHA, Inflammation, and COVID
Inflammation is a normal process that
is a critical part of host defense and tissue
healing. However, excessive and/or unresolved
inflammation can lead to progressive tissue
damage, disease, and pathology. Omega-3
fatty acids are generally considered antiinflammatory, and different mechanisms that
promote these effects have been elucidated.
DHA exhibits antioxidant properties by

decreasing the accumulation of reactive
oxygen species (ROS) such as lipid peroxide
in vivo, which may protect neurons from
oxidative damage and hence prevent neuron
loss. The omega-6 polyunsaturated fatty acid
arachidonic acid (ARA) makes a significant
contribution to the fatty acids present
in the membrane phospholipids of cells
involved in inflammation. ARA is a precursor
to potent pro-inflammatory mediators
including prostaglandins and leukotrienes.
For this reason, many anti-inflammatory
pharmaceuticals have been developed that
target the ARA pathway to successfully
control inflammation. There is also evidence
that a high omega-6 fatty acid diet inhibits
the anti-inflammatory and inflammationresolving effect of omega-3 fatty acids.16
In the recent COVID-19 pandemic,
a section of infected patients experienced
a condition referred to as a “cytokine
storm.”17 A full understanding of the cellular
and molecular mechanisms underlying
the “cytokine storm” has not yet been
unraveled.18 Recent articles suggest that
specific nutrients such as vitamin B6, B12,
C, D, E, and folate; trace elements, including
zinc, iron, selenium, magnesium, and copper
may play a key role in the management
of the cytokine storm.19,20 Among these
micronutrients, long chain PUFAs such as
EPA and DHA are worth mentioning because
of their direct influence in the immunological
response to viral infections.21,22 The
possible beneficial effects of EPA and DHA
supplementation in the modulation of
immune response in SARS-CoV-2 infection
is under investigation.23,24,25,26,27,28 Among
these complex immunomodulatory effects,
interleukin-6 (IL-6) and interleukin-1b
(IL-1b) have been shown to be affected by
dietary EPA and DHA intake. In addition,
poly (ADP-ribose) polymerase enzymes with
anti-inflammatory properties translatable to
human COVID-19 infection were shown
to improve tissue levels of DHA and EPA
and their downstream anti-inflammatory
Missouri Medicine | September/October 2021 | 118:5 | 429
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metabolites,29,30 further underscoring the
applicability of DHA and EPA in the
management of COVID-19. Neutralization of
IL-6 via a monoclonal antibody (Tocilizumab)
has been identified as a feasible therapeutic
target in SARS-CoV-infections,31 nevertheless,
reducing the expression of additional
proinflammatory cytokines (e.g., IL-1b,
IL-38) may have additional therapeutic and
protective effects.32
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